6147-S AMH CALD MORI 138

SSB 6147 - H AMD TO HCW COMM AMD (H-4994.1/18) 1244

By Representative Caldier

WITHDRAWN 02/27/2018

    On page 2, line 3 of the striking amendment, after "(5)" insert "When an issuer adds a new drug to its formulary, it shall notify every enrollee who filled a prescription for a therapeutically equivalent drug within the prior three months of the new drug's availability if the cost of the new drug is fifty percent or lower than the cost of the therapeutically equivalent drug.  The notification must inform the enrollee that he or she should consult with his or her prescribing provider to see if the new drug is appropriate for the enrollee's medical condition.

    (6)"

EFFECT:  Requires an issuer, when it adds a new drug to its formulary, to notify every enrollee who filled a prescription for a therapeutically equivalent drug within the prior three months of the new drug's availability if the cost of the new drug is 50% or lower than the cost of the therapeutically equivalent drug.  Requires the notification to inform the enrollee that he or she should consult with his or her prescribing provider to see if the new drug is appropriate for the enrollee's medical condition. 

--- END ---